SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,245.21 |
| Enterprise Value ($M) | 1,179.61 |
| Book Value ($M) | 329.77 |
| Book Value / Share | 3.62 |
| Price / Book | 3.78 |
| NCAV ($M) | 177.84 |
| NCAV / Share | 1.95 |
| Price / NCAV | 7.00 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.73 |
| Return on Assets (ROA) | -0.43 |
| Return on Equity (ROE) | -0.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.05 |
| Current Ratio | 6.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 241.75 |
| Assets | 393.69 |
| Liabilities | 63.92 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Wellington Management Group Llp | 12.36 | 22.78 | |
| 13G/A | Vanguard Group Inc | 6.04 | 30.12 | |
| 13G/A | BlackRock, Inc. | 6.60 | 6.13 | |
| 13G/A | State Street Corp | 3.58 | -18.79 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| f UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 186,122 | 1,496,128 | 12.44 | |
| 228,241 | 1,323,670 | 17.24 | |
| 244,862 | 940,180 | 26.04 | |
| 165,989 | 876,821 | 18.93 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| QTTB – Q32 Bio Inc. | RANI – Rani Therapeutics Holdings, Inc. |
| RAPT – RAPT Therapeutics, Inc. | RLAY – Relay Therapeutics, Inc. |
| RNA – Avidity Biosciences, Inc. |